NICE Guidance, But Who Does the Work?

被引：1
作者：
Peel, D. N. Y. [1 ]
机构：
[1] Leicester Royal Infirm, Leicester LE1 5WW, Leics, England
来源：
CLINICAL ONCOLOGY | 2011年 / 23卷 / 01期
关键词：
PHASE-II; OXALIPLATIN; THERAPY; CANCER; CARCINOMA; OVARIAN; TRIAL;
D O I：
10.1016/j.clon.2010.09.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 12 条
  • [1] *EUR ASS UR, 2009, EAU PEN CANC GUID
  • [2] Treatment of patients with specific subsets of carcinoma of an unknown primary site
    Fizazi, K.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : X177 - X180
  • [3] National Chemotherapy Advisory Group, 2009, Chemotherapy services in England: ensuring quality and safety a report from the national chemotherapy advisory group
  • [4] National Confidential Enquiry into Patient Outcome and Death, 2008, SYST ANT THER BETT W
  • [5] National Institute for Health and Clinical Excellence, 2010, DIAGN MAN MET MAL DI
  • [6] Oxaliplatin in First-line Therapy for Advanced Non-Small-Cell Lung Cancer
    Raez, Luis E.
    Kobina, Svetlana
    Santos, Edgardo S.
    [J]. CLINICAL LUNG CANCER, 2010, 11 (01) : 18 - 24
  • [7] *ROYAL COLL OBST G, 1992, MAN VULV CANC
  • [8] Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer
    Siemerink, Ester J. M.
    Drenth, Annemieke F. J.
    Mulder, Nanno H.
    Plukker, John T. M.
    Hospers, Geke A. P.
    [J]. GASTRIC CANCER, 2010, 13 (02) : 95 - 100
  • [9] Phase II trial of oxaliplatin and 5-fluorouracil/leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy
    Sundar, S
    Symonds, RP
    Decatris, MP
    Kumar, DM
    Osman, A
    Vasanthan, S
    O'byrne, KJ
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 502 - 508
  • [10] Williams CJ, 2001, COCHRANE DB SYST REV
12